Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley Wysong

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Dermatology and Therapy|February 29, 2024
Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) PatientsAshley Wysong, Ally-Khan Somani, Sherrif F Ibrahim, et al.
Journal of the American Academy of Dermatology|March 19, 2025
Patient-reported quality of life and aesthetic satisfaction continues to improve for 1-year after Mohs surgery: A multicenter prospective cohort studyInge J Veldhuizen, Stephen W Dusza, Alyce Kuo, et al.
Psycho-Oncology|October 18, 2024
Clinical Significance Unveiled: Understanding the Meaning of FACE-Q Skin Cancer Scores for Improved Patient CareInge J Veldhuizen, Stephen W Dusza, Alyce Kuo, et al.
Laryngoscope Investigative Otolaryngology|February 14, 2022
Gene expression profiling for metastatic risk in head and neck cutaneous squamous cell carcinomaSarah T Arron, Ashley Wysong, Mary A Hall, et al.
Future Oncology (London, England)|November 25, 2021
Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile testSherrif F Ibrahim, Julia M Kasprzak, Mary A Hall, et al.
Journal of Cancer Research and Clinical Oncology|November 19, 2020
PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern CaliforniaGino K In, Poorva Vaidya, Alexandra Filkins, et al.
JAMA Dermatology|March 19, 2025
Risk Factor Number and Recurrence, Metastasis, and Disease-Related Death in Cutaneous Squamous Cell CarcinomaNina A Ran, Emily E Granger, David G Brodland, et al.
Journal of the American Academy of Dermatology|February 26, 2025
Identifying the impact of minor risk factors in Brigham and Women's Hospital stage T1 cutaneous squamous cell carcinomas on risk of poor outcomes: A retrospective cohort studyKathryn T Shahwan, Trent D Walker, Andrea Tan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Excision With Total Margin Control Versus Vertical Section Margin Assessment for NCCN Very High-Risk Cutaneous Squamous Cell CarcinomaDavid M Wang, Nina A Ran, Emily E Granger, et al.
American Journal of Clinical Dermatology|September 25, 2025
Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell CarcinomaLindsey M Voller, Kelsey E Hirotsu, Sumaira Z Aasi, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Dermatology and Therapy|February 29, 2024
Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) PatientsAshley Wysong, Ally-Khan Somani, Sherrif F Ibrahim, et al.
Journal of the American Academy of Dermatology|March 19, 2025
Patient-reported quality of life and aesthetic satisfaction continues to improve for 1-year after Mohs surgery: A multicenter prospective cohort studyInge J Veldhuizen, Stephen W Dusza, Alyce Kuo, et al.
Psycho-Oncology|October 18, 2024
Clinical Significance Unveiled: Understanding the Meaning of FACE-Q Skin Cancer Scores for Improved Patient CareInge J Veldhuizen, Stephen W Dusza, Alyce Kuo, et al.
Laryngoscope Investigative Otolaryngology|February 14, 2022
Gene expression profiling for metastatic risk in head and neck cutaneous squamous cell carcinomaSarah T Arron, Ashley Wysong, Mary A Hall, et al.
Future Oncology (London, England)|November 25, 2021
Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile testSherrif F Ibrahim, Julia M Kasprzak, Mary A Hall, et al.
Journal of Cancer Research and Clinical Oncology|November 19, 2020
PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern CaliforniaGino K In, Poorva Vaidya, Alexandra Filkins, et al.
JAMA Dermatology|March 19, 2025
Risk Factor Number and Recurrence, Metastasis, and Disease-Related Death in Cutaneous Squamous Cell CarcinomaNina A Ran, Emily E Granger, David G Brodland, et al.
Journal of the American Academy of Dermatology|February 26, 2025
Identifying the impact of minor risk factors in Brigham and Women's Hospital stage T1 cutaneous squamous cell carcinomas on risk of poor outcomes: A retrospective cohort studyKathryn T Shahwan, Trent D Walker, Andrea Tan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Excision With Total Margin Control Versus Vertical Section Margin Assessment for NCCN Very High-Risk Cutaneous Squamous Cell CarcinomaDavid M Wang, Nina A Ran, Emily E Granger, et al.
American Journal of Clinical Dermatology|September 25, 2025
Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell CarcinomaLindsey M Voller, Kelsey E Hirotsu, Sumaira Z Aasi, et al.
Pageof 11